Mallinckrodt to pay $230 million to settle lawsuit alleging underpayment of medicaid drug rebates localnews8.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from localnews8.com Daily Mail and Mail on Sunday newspapers.
Litigation involving drug price reporting under the Medicaid Drug Rebate Program (MDRP)1 has been very active in 2022. Most recently, on August 3, 2022, an Illinois federal jury.
Litigation involving drug price reporting under the Medicaid Drug Rebate Program (MDRP) has been very active in 2022. Most recently, on August 3, 2022, an Illinois federal jury.
Significant findings from report show that the global market for rare inflammatory disease treatment will increase at an assessed 4.6% CAGR during the forecast period, 2022-2028. The report also anticipates that by 2028-end, rare inflammatory disease treatment worth nearly US$ 17,335.8Mn will be witnessed across the.
Arkansas Attorney General Leslie Rutledge announced the State will settle allegations of fraud against Mallinckrodt ARD, LLC, formerly known as Questcor